Despite having one of the best public health systems in Africa, Botswana has had little success with reducing the prevalence of HIV. About 340,000 adults (23.4% of the population) are infected with HIV, the second highest prevalence rate of HIV of any country in the world.
HIV/AIDS experts have successfully advocated for a more wide-reaching prevention campaign in Botswana to control the epidemic. Their efforts resulted in the Centers for Disease Control and Prevention (CDC) supporting the 4-year Botswana Combination Prevention Project (BCPP).
Supported by a partnership of the Botswana Ministry of Health and Harvard School of Public Health, the study is designed to reduce the number of new HIV infections by promoting coordinated and intensified interventions in 30 communities, including improved HIV testing, counseling, and access to antiretroviral treatment and male circumcision.
- Together with CDC staff, we prepared documents to conduct 400 study site visits to ensure compliance to the research protocol. The visits will ensure that interventions are consistent with the BCPP protocols.
- We recruited individuals from Gaborone and Francistown to join our staff conducting the site visits. Hiring local staff builds Botswana’s capacity for monitoring research.
- The goal of the BCPP is to evaluate the impact of high-quality, large-scale care and treatment services for HIV/AIDS and increase Botswana’s national response to the HIV/AIDs epidemic.